Vyavahare, N <br/><br/>
Inhibition of matrix metalloproteinase activity attenuates tenascin-C production and calcification of implanted purified elastin in rats.  [electronic resource] 

 -  The American journal of pathology  Sep 2000 
 - 885-93 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0002-9440 
<br/><br/><label>Standard No.: </label>10.1016/S0002-9440(10)64602-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkaline Phosphatase--metabolism<br/>Animals<br/>Benzyl Compounds<br/>Calcinosis--metabolism<br/>Dexamethasone--pharmacology<br/>Disease Models, Animal<br/>Drug Combinations<br/>Elastin--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Immunoenzyme Techniques<br/>Implants, Experimental<br/>Male<br/>Matrix Metalloproteinase 2--physiology<br/>Matrix Metalloproteinase 9--physiology<br/>Matrix Metalloproteinase Inhibitors<br/>Pentoxifylline--pharmacology<br/>Protease Inhibitors--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Succinates<br/>Tenascin--biosynthesis